215 related articles for article (PubMed ID: 29786070)
1. Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2.
Hubackova S; Davidova E; Rohlenova K; Stursa J; Werner L; Andera L; Dong L; Terp MG; Hodny Z; Ditzel HJ; Rohlena J; Neuzil J
Cell Death Differ; 2019 Jan; 26(2):276-290. PubMed ID: 29786070
[TBL] [Abstract][Full Text] [Related]
2. Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression.
Jang JY; Jeon YK; Choi Y; Kim CW
Mol Cancer; 2010 Sep; 9():262. PubMed ID: 20875141
[TBL] [Abstract][Full Text] [Related]
3. TGF-β/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence.
Kretova M; Sabova L; Hodny Z; Bartek J; Kollarovic G; Nelson BD; Hubackova S; Luciakova K
Cell Signal; 2014 Dec; 26(12):2903-11. PubMed ID: 25220407
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial PAK6 inhibits prostate cancer cell apoptosis
Li T; Li Y; Liu T; Hu B; Li J; Liu C; Liu T; Li F
Theranostics; 2020; 10(6):2571-2586. PubMed ID: 32194820
[No Abstract] [Full Text] [Related]
5. Chemosensitization by knockdown of adenine nucleotide translocase-2.
Le Bras M; Borgne-Sanchez A; Touat Z; El Dein OS; Deniaud A; Maillier E; Lecellier G; Rebouillat D; Lemaire C; Kroemer G; Jacotot E; Brenner C
Cancer Res; 2006 Sep; 66(18):9143-52. PubMed ID: 16982757
[TBL] [Abstract][Full Text] [Related]
6. Senescent Cell Depletion Through Targeting BCL-Family Proteins and Mitochondria.
Fan Y; Cheng J; Zeng H; Shao L
Front Physiol; 2020; 11():593630. PubMed ID: 33335487
[TBL] [Abstract][Full Text] [Related]
7. Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.
Oishi M; Iizumi Y; Taniguchi T; Goi W; Miki T; Sakai T
PLoS One; 2013; 8(2):e55922. PubMed ID: 23431365
[TBL] [Abstract][Full Text] [Related]
8. Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism.
Chevrollier A; Loiseau D; Reynier P; Stepien G
Biochim Biophys Acta; 2011 Jun; 1807(6):562-7. PubMed ID: 20950584
[TBL] [Abstract][Full Text] [Related]
9. Combined RNA interference of adenine nucleotide translocase-2 and ganciclovir therapy in hepatocellular carcinoma.
Kim JE; Hwang MH; Lee HW; Lee SW; Lee J; Ahn BC
Nucl Med Biol; 2013 Nov; 40(8):987-93. PubMed ID: 24054501
[TBL] [Abstract][Full Text] [Related]
10. Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice.
Was H; Barszcz K; Czarnecka J; Kowalczyk A; Bernas T; Uzarowska E; Koza P; Klejman A; Piwocka K; Kaminska B; Sikora E
Oncotarget; 2017 Feb; 8(6):9303-9322. PubMed ID: 28030837
[TBL] [Abstract][Full Text] [Related]
11. Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer.
Jang JY; Kim YG; Nam SJ; Keam B; Kim TM; Jeon YK; Kim CW
Mol Cancer Ther; 2016 Jun; 15(6):1387-96. PubMed ID: 26883272
[TBL] [Abstract][Full Text] [Related]
12. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.
Jang JY; Lee YS; Jeon YK; Lee K; Jang JJ; Kim CW
Exp Mol Med; 2013 Jan; 45(1):e3. PubMed ID: 23306701
[TBL] [Abstract][Full Text] [Related]
13. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
14. Cellular senescence drives age-dependent hepatic steatosis.
Ogrodnik M; Miwa S; Tchkonia T; Tiniakos D; Wilson CL; Lahat A; Day CP; Burt A; Palmer A; Anstee QM; Grellscheid SN; Hoeijmakers JHJ; Barnhoorn S; Mann DA; Bird TG; Vermeij WP; Kirkland JL; Passos JF; von Zglinicki T; Jurk D
Nat Commun; 2017 Jun; 8():15691. PubMed ID: 28608850
[TBL] [Abstract][Full Text] [Related]
15. Deficiency in the mouse mitochondrial adenine nucleotide translocator isoform 2 gene is associated with cardiac noncompaction.
Kokoszka JE; Waymire KG; Flierl A; Sweeney KM; Angelin A; MacGregor GR; Wallace DC
Biochim Biophys Acta; 2016 Aug; 1857(8):1203-1212. PubMed ID: 27048932
[TBL] [Abstract][Full Text] [Related]
16. The hepatoprotective effects of adenine nucleotide translocator-2 against aging and oxidative stress.
Kim HS; Je JH; Son TG; Park HR; Ji ST; Pokharel YR; Jeon HM; Kang KW; Kang HS; Chang SC; Kim HS; Chung HY; Lee J
Free Radic Res; 2012 Jan; 46(1):21-9. PubMed ID: 22034909
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells.
Jang JY; Kim MK; Jeon YK; Joung YK; Park KD; Kim CW
Exp Mol Med; 2012 Apr; 44(4):251-9. PubMed ID: 22198296
[TBL] [Abstract][Full Text] [Related]
18. A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells.
Park JH; Ahn MY; Kim TH; Yoon S; Kang KW; Lee J; Moon HR; Jung JH; Chung HY; Kim HS
Invest New Drugs; 2012 Oct; 30(5):1887-98. PubMed ID: 21983700
[TBL] [Abstract][Full Text] [Related]
19. Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo.
Jang JY; Choi Y; Jeon YK; Kim CW
Breast Cancer Res; 2008; 10(1):R11. PubMed ID: 18267033
[TBL] [Abstract][Full Text] [Related]
20. Senotherapeutic-like effect of Silybum marianum flower extract revealed on human skin cells.
Woo J; Shin S; Cho E; Ryu D; Garandeau D; Chajra H; Fréchet M; Park D; Jung E
PLoS One; 2021; 16(12):e0260545. PubMed ID: 34914725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
